227 related articles for article (PubMed ID: 31844041)
1. Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
Smadbeck J; Peterson JF; Pearce KE; Pitel BA; Figueroa AL; Timm M; Jevremovic D; Shi M; Stewart AK; Braggio E; Riggs DL; Bergsagel PL; Vasmatzis G; Kearney HM; Hoppman NL; Ketterling RP; Kumar S; Rajkumar SV; Greipp PT; Baughn LB
Blood Cancer J; 2019 Dec; 9(12):103. PubMed ID: 31844041
[TBL] [Abstract][Full Text] [Related]
2. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia.
Aypar U; Smoley SA; Pitel BA; Pearce KE; Zenka RM; Vasmatzis G; Johnson SH; Smadbeck JB; Peterson JF; Geiersbach KB; Van Dyke DL; Thorland EC; Jenkins RB; Ketterling RP; Greipp PT; Kearney HM; Hoppman NL; Baughn LB
Eur J Haematol; 2019 Jan; 102(1):87-96. PubMed ID: 30270457
[TBL] [Abstract][Full Text] [Related]
3. Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.
Rowsey RA; Smoley SA; Williamson CM; Vasmatzis G; Smadbeck JB; Ning Y; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
Blood Cancer J; 2019 Oct; 9(10):81. PubMed ID: 31575852
[TBL] [Abstract][Full Text] [Related]
4. Constitutional chromosome rearrangements that mimic the 2017 world health organization "acute myeloid leukemia with recurrent genetic abnormalities": A study of three cases and review of the literature.
Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Pearce KE; He R; Kelemen K; Al-Mondhiry HAB; Lamparella NE; Hoppman NL; Kearney HM; Baughn LB; Ketterling RP; Greipp PT
Cancer Genet; 2019 Jan; 230():37-46. PubMed ID: 30497985
[TBL] [Abstract][Full Text] [Related]
5. Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis.
Lopes JL; Webley M; Pitel BA; Pearce KE; Smadbeck JB; Johnson SH; Vasmatzis G; Sukov WR; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Finn L; Peterson JF
Cancer Genet; 2020 May; 243():48-51. PubMed ID: 32272434
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal defects in multiple myeloma.
Clarke SE; Fuller KA; Erber WN
Blood Rev; 2024 Mar; 64():101168. PubMed ID: 38212176
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent in situ hybridization studies in multiple myeloma.
Yuregir OO; Sahin FI; Yilmaz Z; Kizilkilic E; Karakus S; Ozdogu H
Hematology; 2009 Apr; 14(2):90-4. PubMed ID: 19298720
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
11. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
[TBL] [Abstract][Full Text] [Related]
12. SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq).
Johnson SH; Smadbeck JB; Smoley SA; Gaitatzes A; Murphy SJ; Harris FR; Drucker TM; Zenka RM; Pitel BA; Rowsey RA; Hoppman NL; Aypar U; Sukov WR; Jenkins RB; Feldman AL; Kearney HM; Vasmatzis G
Cancer Genet; 2018 Feb; 221():1-18. PubMed ID: 29405991
[TBL] [Abstract][Full Text] [Related]
13. Imaging flow cytometric detection of del(17p) in bone marrow and circulating plasma cells in multiple myeloma.
Mincherton TI; Lam SJ; Clarke SE; Hui HYL; Malherbe JAJ; Chuah HS; Sidiqi MH; Fuller KA; Erber WN
Int J Lab Hematol; 2024 Jun; 46(3):495-502. PubMed ID: 38379463
[TBL] [Abstract][Full Text] [Related]
14. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
[TBL] [Abstract][Full Text] [Related]
15. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
[TBL] [Abstract][Full Text] [Related]
16. The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?
Höllein A; Twardziok SO; Walter W; Hutter S; Baer C; Hernandez-Sanchez JM; Meggendorfer M; Haferlach T; Kern W; Haferlach C
Cancer Genet; 2020 Apr; 242():15-24. PubMed ID: 31980417
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics of multiple myeloma.
Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization].
An G; Xie ZQ; Li CH; Li Q; Yi SH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1505-10. PubMed ID: 21176360
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
[TBL] [Abstract][Full Text] [Related]
20. [Fluorescence in situ hybridization on bone marrow smear in the detection of cytogenetic aberrations of multiple myeloma].
Wang XW; Li JY; Chen LJ; Qian SX; Hong M; Qiao C; Zhang JF; Xu W; Lu H; Xu JR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1230-3. PubMed ID: 19840456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]